- Home
- CMPR vs SLNO Comparison
CMPR vs SLNO Comparison
Compare CMPR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPR
- SLNO
- Stock Information
- Founded
- CMPR 1994
- SLNO 1999
- Country
- CMPR Ireland
- SLNO United States
- Employees
- CMPR N/A
- SLNO N/A
- Industry
- CMPR Publishing
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CMPR Consumer Discretionary
- SLNO Health Care
- Exchange
- CMPR Nasdaq
- SLNO Nasdaq
- Market Cap
- CMPR 1.1B
- SLNO 3.8B
- IPO Year
- CMPR N/A
- SLNO 2014
- Fundamental
- Price
- CMPR $49.68
- SLNO $86.65
- Analyst Decision
- CMPR Strong Buy
- SLNO Strong Buy
- Analyst Count
- CMPR 2
- SLNO 9
- Target Price
- CMPR $62.50
- SLNO $103.33
- AVG Volume (30 Days)
- CMPR 321.9K
- SLNO 1.1M
- Earning Date
- CMPR 07-30-2025
- SLNO 08-06-2025
- Dividend Yield
- CMPR N/A
- SLNO N/A
- EPS Growth
- CMPR 83.61
- SLNO N/A
- EPS
- CMPR 5.97
- SLNO N/A
- Revenue
- CMPR $3,366,207,000.00
- SLNO N/A
- Revenue This Year
- CMPR $4.65
- SLNO N/A
- Revenue Next Year
- CMPR $3.16
- SLNO N/A
- P/E Ratio
- CMPR $8.33
- SLNO N/A
- Revenue Growth
- CMPR 3.64
- SLNO N/A
- 52 Week Low
- CMPR $35.21
- SLNO $39.73
- 52 Week High
- CMPR $104.92
- SLNO $87.16
- Technical
- Relative Strength Index (RSI)
- CMPR 66.92
- SLNO 67.62
- Support Level
- CMPR $45.78
- SLNO $81.61
- Resistance Level
- CMPR $50.82
- SLNO $86.79
- Average True Range (ATR)
- CMPR 1.96
- SLNO 3.10
- MACD
- CMPR 0.52
- SLNO 0.33
- Stochastic Oscillator
- CMPR 87.00
- SLNO 95.37
About CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.